Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Sampling Studies × 1 year × Clear all

Sponsor

Conditions

Weight Loss 1 Ovarian Neoplasms 1 Osteochondroma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Nevus, Epithelioid and Spindle Cell 1 Malnutrition 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioblastoma 1 Giant Cell Tumors 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Lobular 1 Carcinoma in Situ 1 Barrett Esophagus 1

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡